Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001178913-23-001080
Filing Date
2023-03-21
Accepted
2023-03-21 16:10:58
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A zk2329412.htm S-1/A 951879
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 208869
3 EXHIBIT 4.2 exhibit_4-2.htm EX-4.2 107258
4 EXHIBIT 4.3 exhibit_4-3.htm EX-4.3 103523
5 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 11672
6 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 13855
7 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 3742
8 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 36205
9 image0.jpg GRAPHIC 125723
10 image00003.jpg GRAPHIC 5150
11 image00005.jpg GRAPHIC 105713
  Complete submission text file 0001178913-23-001080.txt   1764148
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-269218 | Film No.: 23749826
SIC: 2834 Pharmaceutical Preparations